AUTL logo

AUTL
Autolus Therapeutics Ltd - ADR

3,624
Mkt Cap
$455.1M
Volume
217,870.00
52W High
$2.70
52W Low
$1.11
PE Ratio
-2.03
AUTL Fundamentals
Price
$1.68
Prev Close
$1.71
Open
$1.67
50D MA
$1.59
Beta
1.32
Avg. Volume
2.35M
EPS (Annual)
-$0.8652
P/B
2.29
Rev/Employee
$15,648.00
$307.41
Loading...
Loading...
News
all
press releases
Traders Buy Large Volume of Autolus Therapeutics Call Options (NASDAQ:AUTL)
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL - Get Free Report) was the target of unusually large options trading activity on Monday. Traders purchased 2,496 call options on the stock. This...
MarketBeat·7d ago
News Placeholder
More News
News Placeholder
Q1 Earnings Forecast for AUTL Issued By HC Wainwright
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL - Free Report) - Analysts at HC Wainwright issued their Q1 2026 earnings per share estimates for Autolus Therapeutics in a research report issued...
MarketBeat·11d ago
News Placeholder
What is HC Wainwright's Estimate for AUTL FY2025 Earnings?
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL - Free Report) - Investment analysts at HC Wainwright issued their FY2025 earnings per share (EPS) estimates for shares of Autolus Therapeutics in...
MarketBeat·12d ago
News Placeholder
Autolus Therapeutics (NASDAQ:AUTL) Rating Increased to Strong-Buy at HC Wainwright
HC Wainwright raised shares of Autolus Therapeutics to a "strong-buy" rating in a report on Tuesday...
MarketBeat·12d ago
News Placeholder
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Given Average Recommendation of "Hold" by Brokerages
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL - Get Free Report) has been given an average recommendation of "Hold" by the six brokerages that are presently covering the stock, Marketbeat...
MarketBeat·23d ago
News Placeholder
New Strong Sell Stocks for January 30th
TSE, PAC and AUTL have been added to the Zacks Rank #5 (Strong Sell) List on January 30th, 2026.
Zacks·1mo ago
News Placeholder
New Strong Sell Stocks for January 22nd
MHVYF, NFG and AUTL have been added to the Zacks Rank #5 (Strong Sell) List on January 22, 2026.
Zacks·1mo ago
News Placeholder
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Given Consensus Rating of "Moderate Buy" by Brokerages
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL - Get Free Report) has received a consensus rating of "Moderate Buy" from the five brokerages that are currently covering the stock, MarketBeat.com...
MarketBeat·2mo ago
News Placeholder
Needham & Company LLC Has Lowered Expectations for Autolus Therapeutics (NASDAQ:AUTL) Stock Price
Needham & Company LLC lowered their price objective on Autolus Therapeutics from $11.00 to $10.00 and set a "buy" rating on the stock in a research note on Monday...
MarketBeat·2mo ago
News Placeholder
Autolus Therapeutics to Evaluate Automated Manufacturing of AUCATZYL (obe-cel) on the Cellares Cell ShuttleTM Platform
Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, and Cellares Corp, the...
Business Wire·2mo ago
<
1
2
...
>

Latest AUTL News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.